These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 36918759

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Hypoxia and transforming growth factor β1 regulation of long non-coding RNA transcriptomes in human pulmonary fibroblasts.
    Senavirathna LK, Huang C, Pushparaj S, Xu D, Liu L.
    Physiol Rep; 2020 Jan; 8(1):e14343. PubMed ID: 31925944
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
    Gabasa M, Royo D, Molina-Molina M, Roca-Ferrer J, Pujols L, Picado C, Xaubet A, Pereda J.
    PLoS One; 2013 Jan; 8(6):e65445. PubMed ID: 23755232
    [Abstract] [Full Text] [Related]

  • 47. Knockdown of long non‑coding RNA DLEU2 suppresses idiopathic pulmonary fibrosis by regulating the microRNA‑369‑3p/TRIM2 axis.
    Yi H, Luo D, Xiao Y, Jiang D.
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760118
    [Abstract] [Full Text] [Related]

  • 48. Low let-7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis through the TGFβRI/FoxM1/Smad/β-catenin pathway.
    Xie H, Gao YM, Zhang YC, Jia MW, Peng F, Meng QH, Wang YC.
    J Cell Mol Med; 2020 Dec; 24(23):13913-13926. PubMed ID: 33179861
    [Abstract] [Full Text] [Related]

  • 49. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N, Takasaka N, Yoshida M, Tsubouchi K, Minagawa S, Araya J, Saito N, Fujita Y, Kurita Y, Kobayashi K, Ito S, Hara H, Kadota T, Yanagisawa H, Hashimoto M, Utsumi H, Wakui H, Kojima J, Numata T, Kaneko Y, Odaka M, Morikawa T, Nakayama K, Kohrogi H, Kuwano K.
    Respir Res; 2016 Aug 30; 17(1):107. PubMed ID: 27576730
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice.
    Guan S, Liu H, Zhou J, Zhang Q, Bi H.
    Toxicol Lett; 2022 Jun 15; 363():45-54. PubMed ID: 35472619
    [Abstract] [Full Text] [Related]

  • 53. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF, Barron G, Meliton A, Mutlu GM, Dulin NO, Schuger L.
    Am J Respir Cell Mol Biol; 2019 Feb 15; 60(2):221-231. PubMed ID: 30230348
    [Abstract] [Full Text] [Related]

  • 54. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
    Savary G, Dewaeles E, Diazzi S, Buscot M, Nottet N, Fassy J, Courcot E, Henaoui IS, Lemaire J, Martis N, Van der Hauwaert C, Pons N, Magnone V, Leroy S, Hofman V, Plantier L, Lebrigand K, Paquet A, Lino Cardenas CL, Vassaux G, Hofman P, Günther A, Crestani B, Wallaert B, Rezzonico R, Brousseau T, Glowacki F, Bellusci S, Perrais M, Broly F, Barbry P, Marquette CH, Cauffiez C, Mari B, Pottier N.
    Am J Respir Crit Care Med; 2019 Jul 15; 200(2):184-198. PubMed ID: 30964696
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2/3.
    Nakamura H, Zhou Y, Sakamoto Y, Yamazaki A, Kurumiya E, Yamazaki R, Hayashi K, Kasuya Y, Watanabe K, Kasahara J, Takabatake M, Tatsumi K, Yoshino I, Honda T, Murayama T.
    Biomed Pharmacother; 2023 Apr 15; 160():114405. PubMed ID: 36804125
    [Abstract] [Full Text] [Related]

  • 57. Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.
    Ruan H, Gao S, Li S, Luan J, Jiang Q, Li X, Yin H, Zhou H, Yang C.
    Molecules; 2021 May 10; 26(9):. PubMed ID: 34068694
    [Abstract] [Full Text] [Related]

  • 58. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
    Mackinnon AC, Gibbons MA, Farnworth SL, Leffler H, Nilsson UJ, Delaine T, Simpson AJ, Forbes SJ, Hirani N, Gauldie J, Sethi T.
    Am J Respir Crit Care Med; 2012 Mar 01; 185(5):537-46. PubMed ID: 22095546
    [Abstract] [Full Text] [Related]

  • 59. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
    Ghatak S, Hascall VC, Markwald RR, Feghali-Bostwick C, Artlett CM, Gooz M, Bogatkevich GS, Atanelishvili I, Silver RM, Wood J, Thannickal VJ, Misra S.
    J Biol Chem; 2017 Jun 23; 292(25):10490-10519. PubMed ID: 28389561
    [Abstract] [Full Text] [Related]

  • 60. Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway.
    Li X, Wang Y, Liang J, Bi Z, Ruan H, Cui Y, Ma L, Wei Y, Zhou B, Zhang L, Zhou H, Yang C.
    Phytother Res; 2021 Oct 23; 35(10):5808-5822. PubMed ID: 34375009
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.